#AskDrDurie: What Should we know about FDA approval of elotuzumab?

In this week's video, Dr. Brian Durie discusses what patients and caregivers need to know on the recent approval of elotuzumab (Empliciti).

Bottom Line:

Empliciti is a useful drug when used in combination with Rev/dex in a relapse setting.